Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (98.87 KB, 1 trang )
Schistosomiasis— Sub-Saharan Africa
Katayama fever
Schistosoma—
Sub-Saharan Africa
swimmer’s itch
(freshwater),
digger’s itch
(saltwater)
High fever, urticaria,
eosinophilia
weeks after
contact with
freshwater in
endemic areas
Pruritic rash after
skin is penetrated
by schistosomal
cercaria
Laboratory findings include anemia, thrombocytopenia, hypoalbuminemia,
and hypergammaglobulinemia. Untreated visceral infection is nearly always
fatal. Diagnosis of the cutaneous form is through identification of leishmanial
organisms via Wright or Giemsa stain of tissue samples. Visceral disease is
diagnosed via bone marrow (iliac crest in children), spleen, or less commonly,
liver aspirations. Treatment is always indicated for the mucosal and visceral
cases. The drug of choice for visceral and mucosal disease is liposomal
amphotericin B. Miltefosine can be used to treat all three forms and is FDA
approved for patients ≥12 years old. Sodium stibogluconate, an antimonial, has
also been used in the treatment of leishmaniasis, but has multiple potential